Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Effect of bariatric surgery on fatty liver disease in obese patients: A prospective one year follow-up study

D. Toman, P. Vavra, P. Jelinek, P. Ostruszka, P. Ihnat, A. Foltys, A. Pelikan, J. Roman

. 2022 ; 166 (2) : 195-203. [pub] 20210419

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22014549

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD), often associated with obesity and metabolic syndrome, manifests itself as steatosis, hepatic fibrosis, cirrhosis, or even end-stage liver disease. NAFLD causes inflammation, insulin resistance and cardiovascular complications. The current study aimed to evaluate the beneficial effects of bariatric surgery on biochemical parameters of hepatic functions in obese patients by comparing them before and one-year after the surgery. METHODS: A total of 72 morbidly obese patients underwent bariatric surgery between 2016 and 2018. The incidence of diabetes mellitus in this group was 29%, median body weight was 124.5 kg (109.0-140.0) and mean body mass index (BMI) was 44.38 ± 6.770 kg/m2. The used surgical procedures included gastric bypass, sleeve gastrectomy, laparoscopic gastric plication, and single anastomosis duodeno-ileal bypass-sleeve gastrectomy. Biochemical parameters including ALT/AST ratio (AAR), NAFLD fibrosis score (NFS), hepatic fibrosis index (FIB-4) and Fatty Liver Index (FLI) were evaluated in all patients at the time of surgery and one year after the intervention. RESULTS: Significant improvement after the intervention was observed in 64 patients. A significant reduction in body weight (P<0.0001), waist circumference (P<0.0001), and body mass index (P<0.0001) were observed. NAFLD liver fibrosis index changed significantly (P<0.0001), suggesting a trend of improvement from advanced fibrosis towards stages 0-2. The FIB-4 fibrosis index indicated significant improvement (P=0.0136). Besides, a significant decline in hepatic steatosis (P<0.0001) was observed after bariatric surgery as compared to the pre-surgery fatty liver conditions. CONCLUSION: Among the strategies to overcome NAFLD-associated impediments, bariatric surgery can be considered effective in reducing obesity and metabolic co-morbidities. TRIAL REGISTRATION: ClinicalTrials.gov (NCT04569396).

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22014549
003      
CZ-PrNML
005      
20230308092822.0
007      
ta
008      
220602s2022 xr f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2021.021 $2 doi
035    __
$a (PubMed)33885048
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Toman, Daniel, $u Department of Surgery, Faculty of Medicine, Ostrava University, Czech Republic $u Department of Surgery, University Hospital Ostrava, Czech Republic $d 1987- $7 xx0243282
245    10
$a Effect of bariatric surgery on fatty liver disease in obese patients: A prospective one year follow-up study / $c D. Toman, P. Vavra, P. Jelinek, P. Ostruszka, P. Ihnat, A. Foltys, A. Pelikan, J. Roman
520    9_
$a BACKGROUND: Non-alcoholic fatty liver disease (NAFLD), often associated with obesity and metabolic syndrome, manifests itself as steatosis, hepatic fibrosis, cirrhosis, or even end-stage liver disease. NAFLD causes inflammation, insulin resistance and cardiovascular complications. The current study aimed to evaluate the beneficial effects of bariatric surgery on biochemical parameters of hepatic functions in obese patients by comparing them before and one-year after the surgery. METHODS: A total of 72 morbidly obese patients underwent bariatric surgery between 2016 and 2018. The incidence of diabetes mellitus in this group was 29%, median body weight was 124.5 kg (109.0-140.0) and mean body mass index (BMI) was 44.38 ± 6.770 kg/m2. The used surgical procedures included gastric bypass, sleeve gastrectomy, laparoscopic gastric plication, and single anastomosis duodeno-ileal bypass-sleeve gastrectomy. Biochemical parameters including ALT/AST ratio (AAR), NAFLD fibrosis score (NFS), hepatic fibrosis index (FIB-4) and Fatty Liver Index (FLI) were evaluated in all patients at the time of surgery and one year after the intervention. RESULTS: Significant improvement after the intervention was observed in 64 patients. A significant reduction in body weight (P<0.0001), waist circumference (P<0.0001), and body mass index (P<0.0001) were observed. NAFLD liver fibrosis index changed significantly (P<0.0001), suggesting a trend of improvement from advanced fibrosis towards stages 0-2. The FIB-4 fibrosis index indicated significant improvement (P=0.0136). Besides, a significant decline in hepatic steatosis (P<0.0001) was observed after bariatric surgery as compared to the pre-surgery fatty liver conditions. CONCLUSION: Among the strategies to overcome NAFLD-associated impediments, bariatric surgery can be considered effective in reducing obesity and metabolic co-morbidities. TRIAL REGISTRATION: ClinicalTrials.gov (NCT04569396).
650    12
$a bariatrická chirurgie $x škodlivé účinky $7 D050110
650    _2
$a fibróza $7 D005355
650    _2
$a následné studie $7 D005500
650    _2
$a lidé $7 D006801
650    _2
$a játra $7 D008099
650    _2
$a jaterní cirhóza $x komplikace $7 D008103
650    12
$a nealkoholová steatóza jater $x etiologie $x chirurgie $7 D065626
650    12
$a morbidní obezita $x komplikace $x patologie $x chirurgie $7 D009767
650    _2
$a prospektivní studie $7 D011446
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vávra, Petr, $u Department of Surgery, Faculty of Medicine, Ostrava University, Czech Republic $u Department of Surgery, University Hospital Ostrava, Czech Republic $d 1966- $7 xx0070893
700    1_
$a Jelínek, Petr $u Department of Surgery, Faculty of Medicine, Ostrava University, Czech Republic $u Department of Surgery, University Hospital Ostrava, Czech Republic $7 xx0243281
700    1_
$a Ostruszka, Petr $u Department of Surgery, Faculty of Medicine, Ostrava University, Czech Republic $u Department of Surgery, University Hospital Ostrava, Czech Republic $7 xx0231368
700    1_
$a Ihnát, Peter, $u Department of Surgery, Faculty of Medicine, Ostrava University, Czech Republic $u Department of Surgery, University Hospital Ostrava, Czech Republic $d 1978- $7 xx0211685
700    1_
$a Foltys, Aleš $u Department of Surgery, Faculty of Medicine, Ostrava University, Czech Republic $u Department of Surgery, University Hospital Ostrava, Czech Republic $7 xx0093278
700    1_
$a Pelikán, Anton, $u Department of Surgery, Faculty of Medicine, Ostrava University, Czech Republic $u Department of Surgery, University Hospital Ostrava, Czech Republic $u Department of Surgery, St. Mary's Hospital, Newport, Isle of Wight, United Kingdom $u Department of Health Care Sciences, Faculty of Humanities, Tomas Bata University Zlin, Czech Republic $d 1945- $7 nlk19990073678
700    1_
$a Roman, Jan, $u Department of Surgery, Faculty of Medicine, Ostrava University, Czech Republic $u Department of Surgery, University Hospital Ostrava, Czech Republic $d 1993- $7 xx0243196
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $x 1213-8118 $g Roč. 166, č. 2 (2022), s. 195-203
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33885048 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y p $z 0
990    __
$a 20220602 $b ABA008
991    __
$a 20230308092817 $b ABA008
999    __
$a ok $b bmc $g 1824804 $s 1165770
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 166 $c 2 $d 195-203 $e 20210419 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK198 $a Pubmed-20220602

Najít záznam

Citační ukazatele

Možnosti archivace